426 participants
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2025-07-10
- Completion:
- 2028-11-24
Conditions
- Alzheimer Disease
Interventions
- DRUG
No Results Yet